Recall Ledger

BIOFIRE Respiratory Panel 2.1 recall (BioFire Diagnostics, LLC)

Medical deviceClass IIOngoing

Summary: BioFire Diagnostics, LLC is recalling BIOFIRE Respiratory Panel 2.1 (RP2.1) REF 423742 UDI code: 00815381020529 PCR-based multiplexed nucleic acid test, in vitro diagnostic. Reason: Due to increase in false negative results.

What is being recalled

BIOFIRE Respiratory Panel 2.1 (RP2.1) REF 423742 UDI code: 00815381020529 PCR-based multiplexed nucleic acid test, in vitro diagnostic

Why

Due to increase in false negative results

How serious is it

Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.

Where it was sold

U.S. Nationwide distribution in the states of AL, AR, IA, IL, KS, LA, MN, MO, TX, and WI. (states named: Alabama, Arkansas, Iowa, Illinois, Kansas, Louisiana, Minnesota, Missouri, Texas, Wisconsin)

How to tell if yours is affected

Part Number: 423742 UDI-DI code: 00815381020529 Pouch Lot: 3VLB25 Kit Lot: 1872125

What to do

Check the model, lot or serial numbers above against your device. If yours is affected, contact the manufacturer or your healthcare provider before you stop using a device you rely on.

Recall facts

Recall numberZ-2936-2026
CategoryMedical device
AgencyU.S. Food and Drug Administration (FDA)
SeverityClass II
StatusOngoing
Recall startedJune 24, 2026
ReportedAugust 19, 2026
CompanyBioFire Diagnostics, LLC
Company locationSalt Lake City, UT, United States
Initiated byVoluntary: Firm initiated
Quantity2,370 pouches (79 kits)

More recalls from BioFire Diagnostics, LLC · all medical device recalls · recalls from June 2026

Official FDA record